Aurobindo Pharma Ltd (AUROPHARMA) - Financial and Strategic SWOT Analysis Review

Aurobindo Pharma Ltd (AUROPHARMA) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH27497FSA
  • |
  • Pages: 50
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Aurobindo Pharma Ltd (AUROPHARMA)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Aurobindo Pharma Ltd (Aurobindo) is a vertically integrated pharmaceutical company that manufactures and markets generic pharmaceuticals and active pharmaceutical ingredients (APIs). Its product portfolio is spread across major therapeutic and product categories including antibiotics, anti-retroviral, systemic gastroenterological, central nervous system (CNS), cardiovascular, anti-allergies, anti-diabetics, other therapeutic areas. The company also produces novel proprietary biocatalysts, dietary supplements and fermentation based semi synthetic products. Aurobindo operates manufacturing facilities in India, the US, Brazil and Portugal; and R&D facilities in India and the US. The company exports products to several countries worldwide. Aurobindo is headquartered in Hyderabad, Telangana, India.

Aurobindo Pharma Ltd Key Recent Developments

Jan 11,2019: Aurobindo Pharma to launch 147 drugs in different therapeutic segments in next 3 years

Dec 21,2018: Aurobindo Pharma to launch potassium chloride pills in US

Dec 18,2018: Suntuity delivers one of New Jersey's largest rooftop solar PV systems at Aurobindo Pharmaceuticals

Dec 02,2018: Aurobindo Pharma Expects First Biosimilar Approval In U.S. In 12-18 Months

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Aurobindo Pharma Ltd-Key Facts

Aurobindo Pharma Ltd-Key Employees

Aurobindo Pharma Ltd-Key Employee Biographies

Aurobindo Pharma Ltd-Major Products and Services

Aurobindo Pharma Ltd-History

Aurobindo Pharma Ltd-Company Statement

Aurobindo Pharma Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

Aurobindo Pharma Ltd-Business Description

Business Segment: API Segment

Overview

Performance

Business Segment: ARV Formulations

Overview

Performance

Business Segment: EU Formulations

Overview

Performance

Business Segment: Growth Markets Formulations

Overview

Performance

Business Segment: US Formulations

Overview

Performance

Geographical Segment: Europe

Performance

Geographical Segment: India

Performance

Geographical Segment: Rest of the world

Performance

Geographical Segment: USA

Performance

R&D Overview

Aurobindo Pharma Ltd-SWOT Analysis

SWOT Analysis-Overview

Aurobindo Pharma Ltd-Strengths

Aurobindo Pharma Ltd-Weaknesses

Aurobindo Pharma Ltd-Opportunities

Aurobindo Pharma Ltd-Threats

Aurobindo Pharma Ltd-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Aurobindo Pharma Ltd, Recent Deals Summary

Section 5-Company's Recent Developments

Oct 15, 2018: EU authorities take further action in ongoing review of sartans: Zheijiang Huahai placed under increased supervision; Aurobindo Pharma stopped from supplying irbesartan to the EU Share

Jul 17, 2018: Aurobindo to buy Apotex's businesses in five European countries

May 28, 2018: Aurobindo Pharma Q4 FY17-18 and FY17-18 Financial Results

Mar 05, 2018: Aurobindo Pharma Issued Clarification on US FDA Observations

Mar 05, 2018: Aurobindo Announces Inspection of Unit 4 by US FDA

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Figures

Aurobindo Pharma Ltd, Performance Chart (2014-2018)

Aurobindo Pharma Ltd, Ratio Charts

Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

List of Tables

Aurobindo Pharma Ltd, Key Facts

Aurobindo Pharma Ltd, Key Employees

Aurobindo Pharma Ltd, Key Employee Biographies

Aurobindo Pharma Ltd, Major Products and Services

Aurobindo Pharma Ltd, History

Aurobindo Pharma Ltd, Other Locations

Aurobindo Pharma Ltd, Subsidiaries

Aurobindo Pharma Ltd, Joint Venture

Aurobindo Pharma Ltd, Key Competitors

Aurobindo Pharma Ltd, Ratios based on current share price

Aurobindo Pharma Ltd, Annual Ratios

Aurobindo Pharma Ltd, Annual Ratios (Cont...1)

Aurobindo Pharma Ltd, Annual Ratios (Cont...2)

Aurobindo Pharma Ltd, Interim Ratios

Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Aurobindo Pharma Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Mylan NV

Lupin Ltd

Hikal Ltd

Emcure Pharmaceuticals Ltd

Dr. Reddy's Laboratories Ltd

Divi's Laboratories Ltd

Cipla Ltd

Cadila Healthcare Ltd

Aurobindo Pharma Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8620
Site License
USD 250 INR 17240
Corporate User License
USD 375 INR 25860

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com